|
|
|||
|
||||
OverviewCOMBINATORIAL CHEMISTRY AND MOLECULAR DIVERSITY IN DRUG DISCOVERY Edited by Eric M. Gordon and James F. Kerwin, Jr. Increasing pressure to identify, optimize, develop, and commercialize novel drugs more rapidly and more cost-effectively has led to an urgent demand for technologies that can reduce the time to market for new products. Molecular diversity, of both natural and synthetic materials, provides a valuable source of compounds for identifying and optimizing new drug leads. Through the rapidly evolving technology of combinatorial chemistry, it is now possible to produce libraries of small molecules to screen for novel bioactivities. This powerful new technology has begun to help pharmaceutical companies find new drug candidates quickly, save significant dollars in preclinical development costs, and ultimately change their fundamental approach to drug discovery. Comprising the work of the leading authorities in the area of molecular diversity and combinatorial chemistry, Combinatorial Chemistry and Molecular Diversity in Drug Discovery highlights the critical concepts and issues involved in implementing combinatorial chemistry to create chemical libraries. The authors, industrial and academic experts in the field, apply combinatorial technologies to drug discovery and development and place co-evolving technologies and practices in a global framework. Included among the many topics: * Historical background. * Library strategy and design. * Solid-phase synthesis. * Small molecular libraries. * Automation, analytical, and computational methodology. * Biological diversity. * Strategies for screening combinatorial libraries. * Combinatorial drug screening and development. * Combinatorial chemistry information management. Combinatorial Chemistry and Molecular Diversity in Drug Discovery is one of the first comprehensive books to cover this explosive area. It is must reading for medicinal chemists, pharmacologists, molecular biologists, biochemists, enzymologists, and drug discovery research managers in industry, academia, and government. Full Product DetailsAuthor: Eric M. Gordon (Versicor, Inc., Fremont, California) , James F. Kerwin (Abbott Laboratories, Abbott Park, Illinois)Publisher: John Wiley & Sons Inc Imprint: Wiley-Liss Inc.,U.S. Dimensions: Width: 16.40cm , Height: 3.10cm , Length: 23.90cm Weight: 0.903kg ISBN: 9780471155188ISBN 10: 0471155187 Pages: 544 Publication Date: 15 September 1998 Audience: College/higher education , Professional and scholarly , Undergraduate , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Active Availability: Out of stock The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviews...excellent job summarizing many of the important aspects regarding the synthesis, manipulation, and screening of combinatorial molecules for pharmacological activity... (The Quarterly Review of Biology Vol. 76, No. 2, June 2001) This monograph does an excellent job summarizing many of the important aspects regarding the synthesis, manipulation, and screening of combinatorial molecules for pharmacological activity...The editors are to be commended on assembling an admirable resource... (The Quarterly Review of Biology Vol. 76, No. 2, June 2001) Author InformationEric M. Gordon and James F. Kerwin are the authors of Combinatorial Chemistry and Molecular Diversity in Drug Discovery, published by Wiley. Tab Content 6Author Website:Countries AvailableAll regions |
||||